The inspirational value is clear for Lions Health attendees, but there is still confusion about what good looks like for branded pharma campaigns, and how the US fits in.
It's not only a venue to gain creative inspiration, but a good place to scout talent, and there are no lack of strategic meetings underway in Cannes.
The second annual Lions Health creativity festival ended Saturday.
The Lions Health award winners will be announced later Friday at an event in Cannes, France.
Merck settles a marketing lawsuit for $5.9 million; CVS plans to create diagnostic apps; a survey shows advertising agencies plan to keep head count steady for the rest of the year
Medscape marked its 20th anniversary with a reunion this week that attracted staffers from the portal's earliest days.
The three-year-old campaign's youthful tone evolves as its audience ages.
Havas Health developed the inhaled insulin's advertising campaign, which is slated to kick off later this summer.
The Lions Health jurors in 2014 declined to award the top prize in the pharma category, raising questions about how the industry's creativity stacks up against the world's top marketers.
He spoke with MM&M about whether pharma is ready to win a Grand Prix, if regulation limits creativity in healthcare, and why wearables may spur creativity.
Amgen's PSCK9 inhibitor gets a position opinion in the EU; the FDA plans to study how spouses influence perception of DTC ads; Botox may relieve depression
The new Centron includes renamed medical education, public relations and market access divisions.
The digital health firm is expanding services to pharma customers, offering to help drugmakers maximize spending on TV and video.
The company said revenue from pharmaceutical and medical device sponsorships and advertisements rose 10.7% but the company put some initiatives on hold.
A deep dive by the think tank Center for Talent Innovation indicates pharma and payers need to widen their definition of health when communicating with women.
The holding company said pharma and health made up 11% of revenues during the first three months of the year.
Wego Health says fixing this problem requires incorporating patient perspectives before and after a product launch.
A more general warning encourages consumers to engage in a personal discussion with their doctor about a drug, and it promotes engagement with longer-format printed or digitally-delivered information.
J&J sues GlaxoSmithKline over Flonase ads, CDC report finds patients with invasive cancer are living for five years or longer have diagnosis, and Bristol-Myers Squibb resubmits its HCV treatment.
Smartphones drove network traffic.
The Trustworthy Accountability of National Advertisers launched its naming-names initiative in November, but the list is empty.
23andMe is back in the DTC game; Sanofi has named its new CEO; drug companies are contemplating a pay-for-performance sales model.
FDA posted a revised draft guidance document on its brief summary and adequate directions for use concerning risk information in DTC print ads to reflect "recent social science research."
The list of objections by the Office of Prescription Drug Promotion, which oversees medical advertising, is a familiar one, and includes concerns such as claims that go beyond the approved indication.
FDA's latest guidance says it is ok to reduce the amount of risk information in print ads, Google amplifies the health information it will serve up with searches and HBO's John Oliver takes on pharmaceutical marketing.
Tina Fascetti is the mid-sized agency's new Chief Creative Officer. CEO Matt Brown (and ICC Lowe alum) tells MM&M the new Guidemark is just getting started.
The FDA is looking into whether abbreviated risk information is a good idea for DTC.
MAHF 2015 Heritage Ad Awards will be given to campaigns for Bentyl, Hytrin and Navane
With the purchase of Olson Communications, the agency aims to serve clients eager for expertise from outside the healthcare industry.
The Austin agency says it beat out FCB, Ogilvy CommonHealth, GSW Worldwide and H4B Chelsea for the work.
What does going "beyond the pill" actually mean? At MM&M's recent inaugural spring conference, audience members heard from real-world companies that are managing the organizational, technological, and promotional challenges inherent in this transition, such as partnering with health neophytes, harnessing technologies that allow deeper engagement with patients, and adopting a new commercial mindset to serve, not sell. Download here.
A wave of more effective anti-cancer drugs has set the oncology world on fire with enthusiasm. While many hail this as a new era, an equally vocal faction questions the money spent for the value gained. This medical and commercial trend report for marketers of anti-cancer modalities touches on many of the latest shifts that have expedited product launches and otherwise impacted promotion and reimbursement of these drugs. Click here.